RESUMEN
Tryparedoxins (TXNs) are trypanothione-dependent peroxiredoxin oxidoreductases involved in hydroperoxide detoxification that have been shown to determine virulence in trypanosomatids. The structure of (15)N,(13)C-doubly-labeled, C-terminally-His-tagged tryparedoxin 1 from Crithidia fasciculata (Cf TXN1) was elucidated by three-dimensional NMR spectroscopy. Global folding was found to be similar to the crystal structure, but regions near the active site, especially the onset of helix alpha1 with the redox-active Cys 43 and helix alpha2 relevant to substrate binding, were less well defined in solution. The redox-inactive inhibitory substrate analogue N(1),N(8)-bis(ophthalmyl)spermidine was used to study the substrate/TXN interaction by two-dimensional (1)H,(15)N NMR spectroscopy. The NMR data complemented by molecular modeling revealed several alternative modes of ligand binding. The results confirm and extend the concept of TXN action and specificity derived from X-ray analysis and site-directed mutagenesis and thus improve the rational basis for inhibitor design.
Asunto(s)
Glutatión/análogos & derivados , Proteínas Protozoarias/química , Proteínas Protozoarias/metabolismo , Espermidina/análogos & derivados , Tiorredoxinas/química , Tiorredoxinas/metabolismo , Animales , Simulación por Computador , Crithidia , Cristalografía por Rayos X , Activación Enzimática , Glutatión/química , Modelos Moleculares , Resonancia Magnética Nuclear Biomolecular , Oxidación-Reducción , Oxidorreductasas/antagonistas & inhibidores , Oxidorreductasas/química , Soluciones , Espermidina/química , Especificidad por Sustrato , Tiorredoxinas/antagonistas & inhibidoresRESUMEN
Several amines, amino acid derivatives and low molecular weight peptides containing an amide-bound oxal hydroxamic acid moiety have been synthesized and tested for their inhibitory effects towards native human gelatinase B (MMP-9) and the catalytic domains of the membrane type MT1-MMP (MMP-14) and of neutrophil collagenase (MMP-8). A number of these compounds exhibited considerable inhibitory activity against the tested metalloproteinases.
Asunto(s)
Ácidos Hidroxámicos/farmacología , Inhibidores de la Metaloproteinasa de la Matriz , Aminas/síntesis química , Aminas/farmacología , Aminoácidos/síntesis química , Aminoácidos/farmacología , Dominio Catalítico , Humanos , Ácidos Hidroxámicos/síntesis química , Ácidos Hidroxámicos/química , Metaloproteinasa 8 de la Matriz/química , Metaloproteinasa 9 de la Matriz/química , Metaloproteinasas de la Matriz/química , Oligopéptidos/síntesis química , Oligopéptidos/farmacología , Relación Estructura-ActividadRESUMEN
Tryparedoxin peroxidase (TXNPx) of Trypanosomatidae is the terminal peroxidase of a complex redox cascade that detoxifies hydroperoxides by NADPH (Nogoceke et al., Biol. Chem. 378, 827-836, 1997). A gene putatively coding for a peroxiredoxin-type TXNPx was identified in L. donovani and expressed in Escherichia coli to yield an N-terminally His-tagged protein (LdH6TXNPx). LdH6TXNPx proved to be an active peroxidase with tryparedoxin (TXN) 1 and 2 of Crithidia fasciculata as cosubstrates. LdH6TXNPx efficiently reduces H2O2, is moderately active with t-butyl and cumene hydroperoxide, but only marginally with linoleic acid hydroperoxide and phosphatidyl choline hydroperoxide. The enzyme displays ping-pong kinetics with a k(cat) of 11.2 s(-1) and limiting K(m) values for t-butyl hydroperoxide and CfTXN1 of 50 and 3.6 microM, respectively. Site-directed mutagenesis confirmed that C52 and C173, as in related peroxiredoxins, are involved in catalysis. Exchanges of R128 against D and T49 against S and V, supported by molecular modelling, further disclose that the SH group of C52 builds the center of a novel catalytic triad. By hydrogen bonding with the OH of T49 and by the positive charge of R128 the solvent-exposed thiol of C52 becomes deprotonated to react with ROOH. Molecular models of oxidized TXNPx show C52 disulfide-bridged with C173' that can be attacked by C41 of TXN2. By homology, the deduced mechanism may apply to most peroxiredoxins and complements current views of peroxiredoxin catalysis.